A SPAC III Acquisition Corp. Class A Ordinary Shares (ASPC) Dividend History
A SPAC III Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify and acquire a target business in the future. As a blank-check company, it raises capital through an initial public offering with the intention of merging with or acquiring an existing company, providing a pathway for private companies to go public through a merger.
Dividend History
A SPAC III Acquisition Corp. Class A Ordinary Shares currently does not pay dividends
Company News
-
Class Action Attorney Juan Monteverde is investigating the proposed mergers of A SPAC III Acquisition Corp., Informatica Inc., and BioSig Technologies, Inc. to ensure that shareholders' interests are protected.
GlobeNewswire Inc. -
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. ECMOHO Limited (NASDAQ: MOHO) jumped 146.1% to settle at $0.4085 on above-average volume. Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares climbed 145.3% to close at $1.58 on Wednesday after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ: KSPN) jumped 140.3% to close at $6.20. Enveric Biosciences, Inc. (NASDAQ: ENVB) gained 106% to settle at $13.10. Enveric Biosciences recently announced an $8 million registered direct offering and private placement. Heart Test Laboratories, Inc. (NASDAQ: HSCS) jumped 89.6% to close at $3.28. Poseida Therapeutics, Inc. (NASDAQ: PSTX) shares surged 85.6% to close at $4.51 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. Eargo, Inc. (NASDAQ: EAR) shares gained 75.6% to settle at $1.23. The company is scheduled to report Q2 earnings on Monday, August 8. Winc, Inc. (NYSE: WBEV) rose 71.4% to close at $2.16. Cuentas Inc. (NASDAQ: CUEN) gained 70.1% to close at $0.9014. Shares of several companies in the broader communications, entertainment and media industry traded higher amid strength in the overall market and positive overall market sentiment following recent earnings. Ping Identity Holding Corp. (NYSE: PING) shares jumped 60.7% to close at $28.08 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash. Ping Identity also posted a Q2 loss of $0.34 per share. American Rebel Holdings, Inc. (NASDAQ: AREB) gained 58.7% to settle at $1.00. Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) surged 49.3% to settle at $212.01 after the company announced the results from its APOLLO-B Phase 3 study of patisiran met the primary endpoint and also met the first secondary endpoint. MediaCo Holding Inc. (NASDAQ: MDIA) jumped 49.1% to settle at $5.65 after climbing around 14% on Tuesday. Standard General recently purchased roughly 12.9 million shares, bringing ownership to 92.4%. Otonomy, Inc. (NASDAQ: OTIC) gained 48.4% to close at $0.37. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints. Applied DNA Sciences, Inc. (NASDAQ: APDN) jumped 46.4% to close at $4.10 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) gained 45.8% to close at $1.75 after the company announced a $3.5 million accelerated milestone payment from Zimmer Biomet. The amendment will also provide Zimmer with 350,000 warrants with an exercise price of $3.00 per share. Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 42.5% to close at $1.04. Chembio Diagnostics is expected to release financial results for the second quarter after the close of trading on Thursday, August 4, 2022. Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 38.3% to close at $0.2450 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million. Akso Health Group (NASDAQ: AHG) jumped 37.6% to close at $1.30. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 35.2% to settle at $1.46. Shares of several companies in the broader consumer discretionary sector traded higher amid overall market strength. Lottery.com Inc. (NASDAQ: LTRY) jumped 34.3% to settle at $0.4701. Brickell Biotech, Inc. (NASDAQ: BBI) gained 33% to close at $4.19. Tupperware Brands Corporation (NYSE: TUP) surged 32.4% to close at $9.53 after the company reported better-than-expected Q2 results. Senseonics Holdings, Inc. (NYSE: SENS) gained 31.5% to settle at $1.67. Alaunos Therapeutics, Inc. (NASDAQ: TCRT) climbed 31.4% to close at $1.55. Leju Holdings Limited (NYSE: LEJU) gained 28.5% to settle at $2.9931. SoFi Technologies, Inc. (NASDAQ: SOFI) climbed 28.4% to close at $8.23 after the company reported better-than-expected Q2 results and raised FY22 guidance. Endo International plc ...
BenzingaFeatured Companies: AIZ ALNY APDN APWC AREB ARQT ASAN BGFV CLW COIN CWH CYH DFIN DUO EGY ENVB GBIO GSUN HLF HOOD HSCS HSDT HYFM IONS KN LCFY LEDS LTRY MAIA MDIA MGTX MHUA MRCY MRNA MSPR MTC MTCH NA NMTC NVFY OESX OKYO OMI PASG PYPL RCKY RYTM SEDG SENS SHOP SMLR SOFI SPT SQ SWX TCRT TGI UNM UPST VMD W XCUR -
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ: KSPN) gained 112.4% to $5.48. Eargo, Inc. (NASDAQ: EAR) shares climbed 102.8% to $1.42. The company is scheduled to report Q2 earnings on Monday, August 8. Poseida Therapeutics, Inc. (NASDAQ: PSTX) shares jumped 99.6% to $4.85 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. Applied DNA Sciences, Inc. (NASDAQ: APDN) climbed 75.7% to $4.92 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus. Kintara Therapeutics, Inc. (NASDAQ: KTRA) gained 70% to $0.3013 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million. Ping Identity Holding Corp. (NYSE: PING) shares climbed 59.8% to $27.92 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash. Ping Identity also posted a Q2 loss of $0.34 per share. Otonomy, Inc. (NASDAQ: OTIC) jumped 56% to $0.3887. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints. Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) jumped 48% to $210.17 after the company announced the results from its APOLLO-B Phase 3 study of patisiran met the primary endpoint and also met the first secondary endpoint. Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares gained 48% to $1.08. Chembio Diagnostics is expected to release financial results for the second quarter after the close of trading on Thursday, August 4, 2022. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) gained 40% to $1.6850 after the company announced a $3.5 million accelerated milestone payment from Zimmer Biomet. The amendment will also provide Zimmer with 350,000 warrants with an exercise price of $3.00 per share. Endo International plc (NASDAQ: ENDP) gained 38% to $0.8099. Tupperware Brands Corporation (NYSE: TUP) jumped 37% to $9.90 after the company reported better-than-expected Q2 results. Tuniu Corporation (NASDAQ: TOUR) shares rose 25.2% to $1.0094 after dropping over 9% on Tuesday. Rubius Therapeutics, Inc. (NASDAQ: RUBY) jumped 24% to $0.85. ECMOHO Limited (NASDAQ: MOHO) gained 23.7% to $0.2054. Clearwater Paper Corporation (NYSE: CLW) rose 22.3% to $42.56 following strong quarterly sales. Donnelley Financial Solutions, Inc. (NASDAQ: DFIN) jumped 22.2% to $41.06 after the company reported better-than-expected Q2 results. SoFi Technologies, Inc. (NASDAQ: SOFI) rose 22.1% to $7.84 after the company reported better-than-expected Q2 results and raised FY22 guidance. Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) jumped 20.2% to $23.43. Arcutis Biotherapeutics priced its ...
Benzinga -
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.45% to 32,540.68 while the NASDAQ rose 1.43% to 12,525.90. The S&P also rose, gaining, 0.71% to 4,120.15. Also check this: Starbucks, Yum! Brands And 3 Stocks To Watch Heading Into Wednesday Leading and Lagging Sectors Communication services shares climbed 1.7% on Wednesday. Meanwhile, top gainers in the sector included Perion Network Ltd. (NASDAQ: PERI), up 7% and Golden Matrix Group, Inc. (NASDAQ: GMGI) up 8%. In trading on Wednesday, utilities shares fell 1.1%. Top Headline The ISM Services PMI unexpectedly rose to 56.7 in July, recording the highest level in three months, compared to June’s reading of 55.3. However, analysts were expecting a reading of 53.5. Equities Trading UP Poseida Therapeutics, Inc. (NASDAQ: PSTX) shares shot up 108% to $5.05 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. Shares of Applied DNA Sciences, Inc. (NASDAQ: APDN) got a boost, shooting 76% to $4.9284 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic ...
Benzinga -
Upgrades According to Janney Montgomery Scott, the prior rating for Berkshire Hills Bancorp Inc (NYSE:BHLB) was changed from Neutral to Buy. Berkshire Hills Bancorp earned $0.51 in the second quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $31.78 and a 52-week-low of $23.15. At the end of the last trading period, Berkshire Hills Bancorp closed at $27.14. For Brixmor Property Group Inc (NYSE:BRX), Mizuho upgraded the previous rating of Neutral to Buy. Brixmor Property Group earned $0.49 in the first quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $27.19 and a 52-week-low of $19.42. At the end of the last trading period, Brixmor Property Group closed at $21.82. Loop Capital upgraded the previous rating for CSX Corp (NASDAQ:CSX) from Hold to Buy. In the second quarter, CSX showed an EPS of $0.50, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $38.63 and a 52-week-low of $27.59. CSX closed at $29.73 at the end of the last trading period. Wells Fargo upgraded the previous rating for Las Vegas Sands Corp (NYSE:LVS) from Equal-Weight to Overweight. Las Vegas Sands earned $0.34 in the second quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $49.63 and a 52-week-low of $28.88. At the end of the last trading period, Las Vegas Sands closed at $37.08. For IDEXX Laboratories Inc (NASDAQ:IDXX), Goldman Sachs upgraded the previous rating of Neutral to Buy. IDEXX Laboratories earned $2.27 in the first quarter, compared to $2.35 in the year-ago quarter. The stock has a 52-week-high of $706.95 and a 52-week-low of $318.50. At the end of the last trading period, IDEXX Laboratories closed at $383.81. See all analyst ratings upgrades. Downgrades Deutsche Bank downgraded the previous rating for Stryker Corp (NYSE:SYK) from Buy to Hold. Stryker earned $1.97 in the first quarter, compared to $1.93 in the year-ago quarter. The stock has a 52-week-high of $281.16 and a 52-week-low of $188.84. At the end of the last trading period, Stryker closed at $198.05. Mizuho downgraded the previous rating for Phillips Edison & Co Inc (NASDAQ:PECO) from Buy to Neutral. For the first quarter, Phillips Edison had an EPS of $0.09, compared to year-ago quarter EPS of $0.00. At the moment, the stock has a 52-week-high of $36.35 and a 52-week-low of $27.14. Phillips Edison closed at $33.94 at the end of the last trading period. For Shift Technologies Inc (NASDAQ:SFT), William Blair downgraded the previous rating of Outperform to Market Perform. In the first quarter, Shift Technologies showed an EPS of $0.70, compared to $0.55 from the year-ago quarter. The stock has a 52-week-high of $9.75 and a 52-week-low of $0.60. At the end of the last trading period, Shift Technologies closed at $1.15. For Traeger Inc (NYSE:COOK), Telsey Advisory Group downgraded the previous rating of Outperform to Market Perform. In the first quarter, Traeger showed an EPS of $0.17, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.59 and a 52-week-low of $3.84. Traeger closed at $3.95 at the end of the last trading period. Raymond James downgraded the previous rating for Invitae Corp (NYSE:NVTA) from Outperform to Market Perform. For the first quarter, Invitae had an EPS of $0.78, compared to year-ago quarter EPS of $0.63. The current stock performance of Invitae shows a 52-week-high of $32.93 and a 52-week-low of $2.08. Moreover, at the end of the last trading period, the closing price was at $2.34. Chardan Capital downgraded the previous rating for Vascular Biogenics Ltd (NASDAQ:VBLT) from Buy to Neutral. In the first quarter, Vascular Biogenics showed an EPS of $0.13, compared to $0.12 from the year-ago quarter. The stock has a 52-week-high of $2.54 and a 52-week-low of $0.40. At the end of the last trading period, Vascular Biogenics closed at $0.42. According to Piper Sandler, the prior rating for DocuSign Inc (NASDAQ:DOCU) was changed from Neutral to Underweight. DocuSign earned $0.38 in the first quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $314.76 and a 52-week-low of $55.86. At the end of the last trading period, DocuSign closed at $67.66. For FIGS Inc (NYSE:FIGS), Goldman Sachs downgraded the previous rating of Neutral to Sell. For the first quarter, FIGS had an EPS of $0.05, compared to year-ago quarter EPS of $0.08. The current stock performance of FIGS shows a 52-week-high of $48.63 and a 52-week-low of $6.93. Moreover, at the end of the last trading period, the closing price was at $10.63. Goldman Sachs downgraded the previous rating for PVH Corp (NYSE:PVH) from Buy to Neutral. PVH earned $1.94 in the first quarter, compared to $1.92 in the year-ago quarter. The current stock performance of PVH shows a 52-week-high of $125.42 and a 52-week-low of $54.57. Moreover, at the end of the last trading period, the closing price was at $63.40. Goldman Sachs downgraded the previous rating for Henry Schein Inc (NASDAQ:HSIC) from Buy to Neutral. Henry Schein earned $1.30 in the first quarter, compared to $1.24 in the year-ago quarter. The current stock performance of Henry Schein shows a 52-week-high of $92.68 and a 52-week-low of $70.25. Moreover, at the end of the last trading period, the closing price was at $78.00. Goldman Sachs downgraded the previous rating for Elanco Animal Health Inc (NYSE:ELAN) from Buy to Sell. In the first quarter, Elanco Animal Health showed an EPS of $0.36, compared to $0.37 from the year-ago quarter. The current stock performance of Elanco Animal Health shows a 52-week-high of $37.49 and a 52-week-low of $19.11. Moreover, at the end of the last trading period, the closing price was at $20.56. According to Morgan ...Full story available on Benzinga.com
Benzinga